The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
NCT ID: NCT04577248
Last Updated: 2020-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2020-09-15
2031-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
German Registry for Transcatheter Tricuspid Valve Interventions
NCT04653428
Valvular Heart Disease Registry
NCT03488732
The Prospective Segeberg Registry for Mitral Transcatheter Edge-to-Edge Repair
NCT07045753
Transcatheter Treatment for Combined Aortic and Mitral Valve Disease. The Aortic+Mitral TRAnsCatheter (AMTRAC) Valve Registry
NCT04031274
Outcomes of Patients tReated wIth Mitral Transcatheter Edge-to-edge Repair for Primary Mitral Regurgitation Registry
NCT05332782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
edge-to-edge valve repair
edge-to-edge valve repair
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
* Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
* Written informed consent
Exclusion Criteria
18 Years
110 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Deutsches Herzzentrum Muenchen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick Mayr, MD
Role: STUDY_CHAIR
Dept. of Anesthesiology, Deutsches Herzzentrum München
Michael Joner, Prof
Role: STUDY_CHAIR
Dept. of Cardiology, Deutsches Herzzentrum München
Tobias Rheude, MD
Role: PRINCIPAL_INVESTIGATOR
Dept. of Cardiology, Deutsches Herzzentrum München
Costanza Pellegrini, MD
Role: PRINCIPAL_INVESTIGATOR
Dept. of Cardiology, Deutsches Herzzentrum München
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München
Munich, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GE DHM-AN-EHK-2020/09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.